GB2245061A - Modelling thrombosis formation - Google Patents
Modelling thrombosis formation Download PDFInfo
- Publication number
- GB2245061A GB2245061A GB9006520A GB9006520A GB2245061A GB 2245061 A GB2245061 A GB 2245061A GB 9006520 A GB9006520 A GB 9006520A GB 9006520 A GB9006520 A GB 9006520A GB 2245061 A GB2245061 A GB 2245061A
- Authority
- GB
- United Kingdom
- Prior art keywords
- blood
- tube
- sleeve
- formation
- tubing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 208000007536 Thrombosis Diseases 0.000 title claims abstract description 37
- 230000015572 biosynthetic process Effects 0.000 title claims abstract description 34
- 239000008280 blood Substances 0.000 claims abstract description 56
- 210000004369 blood Anatomy 0.000 claims abstract description 56
- 238000000034 method Methods 0.000 claims abstract description 24
- 230000000740 bleeding effect Effects 0.000 claims abstract description 13
- 238000005755 formation reaction Methods 0.000 claims description 35
- 102000008186 Collagen Human genes 0.000 claims description 17
- 108010035532 Collagen Proteins 0.000 claims description 17
- 229920001436 collagen Polymers 0.000 claims description 17
- 238000004080 punching Methods 0.000 claims description 16
- 239000000463 material Substances 0.000 claims description 15
- 239000002729 catgut Substances 0.000 claims description 12
- 210000004204 blood vessel Anatomy 0.000 claims description 8
- 230000000694 effects Effects 0.000 claims description 6
- 241001465754 Metazoa Species 0.000 claims description 5
- 229920002379 silicone rubber Polymers 0.000 claims description 5
- 239000004945 silicone rubber Substances 0.000 claims description 5
- 239000002699 waste material Substances 0.000 claims description 5
- 238000004458 analytical method Methods 0.000 claims description 4
- 238000000338 in vitro Methods 0.000 claims description 4
- 238000003780 insertion Methods 0.000 claims description 2
- 230000037431 insertion Effects 0.000 claims description 2
- 239000012530 fluid Substances 0.000 claims 1
- 230000001939 inductive effect Effects 0.000 claims 1
- 230000000541 pulsatile effect Effects 0.000 claims 1
- 238000005086 pumping Methods 0.000 claims 1
- 230000023597 hemostasis Effects 0.000 abstract description 9
- 210000001367 artery Anatomy 0.000 abstract description 8
- 239000004698 Polyethylene Substances 0.000 description 8
- -1 polyethylene Polymers 0.000 description 8
- 229920000573 polyethylene Polymers 0.000 description 8
- 239000005662 Paraffin oil Substances 0.000 description 5
- 230000017531 blood circulation Effects 0.000 description 4
- 239000000835 fiber Substances 0.000 description 4
- 238000004088 simulation Methods 0.000 description 4
- 230000009977 dual effect Effects 0.000 description 3
- 229920001971 elastomer Polymers 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 230000001154 acute effect Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 230000033001 locomotion Effects 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 206010003178 Arterial thrombosis Diseases 0.000 description 1
- 208000037260 Atherosclerotic Plaque Diseases 0.000 description 1
- 208000019838 Blood disease Diseases 0.000 description 1
- 206010053567 Coagulopathies Diseases 0.000 description 1
- 208000001778 Coronary Occlusion Diseases 0.000 description 1
- 206010011086 Coronary artery occlusion Diseases 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 208000031481 Pathologic Constriction Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 229940030225 antihemorrhagics Drugs 0.000 description 1
- 230000003143 atherosclerotic effect Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 230000035602 clotting Effects 0.000 description 1
- 239000000701 coagulant Substances 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000000025 haemostatic effect Effects 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 208000018706 hematopoietic system disease Diseases 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000011005 laboratory method Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 230000003950 pathogenic mechanism Effects 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 230000029305 taxis Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/22—Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/49—Blood
- G01N33/4905—Determining clotting time of blood
-
- G—PHYSICS
- G09—EDUCATION; CRYPTOGRAPHY; DISPLAY; ADVERTISING; SEALS
- G09B—EDUCATIONAL OR DEMONSTRATION APPLIANCES; APPLIANCES FOR TEACHING, OR COMMUNICATING WITH, THE BLIND, DEAF OR MUTE; MODELS; PLANETARIA; GLOBES; MAPS; DIAGRAMS
- G09B23/00—Models for scientific, medical, or mathematical purposes, e.g. full-sized devices for demonstration purposes
- G09B23/28—Models for scientific, medical, or mathematical purposes, e.g. full-sized devices for demonstration purposes for medicine
- G09B23/285—Models for scientific, medical, or mathematical purposes, e.g. full-sized devices for demonstration purposes for medicine for injections, endoscopy, bronchoscopy, sigmoidscopy, insertion of contraceptive devices or enemas
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- General Physics & Mathematics (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Surgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Immunology (AREA)
- Ecology (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biophysics (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Food Science & Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Veterinary Medicine (AREA)
- Pathology (AREA)
- Pulmonology (AREA)
- Radiology & Medical Imaging (AREA)
- Algebra (AREA)
- Computational Mathematics (AREA)
- Mathematical Analysis (AREA)
- Mathematical Optimization (AREA)
- Mathematical Physics (AREA)
- Pure & Applied Mathematics (AREA)
- Business, Economics & Management (AREA)
- Educational Administration (AREA)
- Educational Technology (AREA)
- Theoretical Computer Science (AREA)
Abstract
Apparatus and method for modeling of thrombogenesis using haemostasis measuring devices. A sleeve member is provided on a blood-carrying tube to simulate an environment of a human artery. When punctured with a small needle, bleeding is simulated, permitting blood to be trapped between the sleeve and blood-carrying tube. The trapped blood communicates with the blood flowing in the tube, resulting in thrombus formation.
Description
APPARATt;S AND METHOD FOR MODELING
ARTERIAL THRONBUS FORMATIONS
The present invention relates to the simulation and monitoring of arterial thrombus formations. Specifically, a method of modeling thrombus formations using haemost measuring devices is disclosed.
Arterial thrombosis is essentially a platelet plug formation on a damaged vessel wall. Normally, the lumen of the vessel wall is lined by a non-thro#ogenic layer. when the deeper layers of the vessel wall are exposed to the flowing blood through damage, it is mainly collagen fibers e#nbedded into the connective tissue which activates platelets and set in notion a chain of events leading to a sudden thrombus formation. The collagen-platelet interaction is therefore the major contributor to thrombogenesis.
Measurements of the physical attributes of blood in vitro has been described in previous patents and patent applications of the inventor. In PCT/GB87/OO633, there is described a dual channel device for measuring various haemostasis clotting and the like properties of blood, and specifically to apparatus enabling measurements of such quantities to be made on blood.
In the device described in the aforesaid published patent application, there is described a technique which permits the simulation of flowing blood through an artery, and the consequences of, a sudden puncture to the tube carrying the flowing blood, thus simulating bleeding.
Described in the aforesaid published patent is a technique which permits the analysis of platelet plug-formation when a piece of collagen material is introduced into the flowing bloodstream, The collagen interacts with the flowing blood to activate platelets which result in thrombus formation on the surface of the collagen The progress of thrombus formation is monitored by observing the blood flow in the tube, as indicated by the pressure at the distal end of the tub discharging the stream of blood. The formation of the thrombus on the collagen material eventually produces a pressure pattern which is indicative of the occlusion of the tube, thus modeling an arterial thrombogenesis occurring in a human blood vessel.
The present invention is a continuation of these efforts to measure the thrombosis formation using the apparatus and techniques described in the earlier-published patent application.
We will therefore describe an arrangement to accurately model arterial thrombus formation in vitro.
The described arrangement will permit mcdeling of thrombogenesis which taxes into account other factors contributing to the formation of a thrombus.
We will describe a
method for preparing collagen material for introduction in a flowing bloodstream to measure platelet formation.
These and cther.mattcrs are accomplished with apparatus and methods using the haemostasis measuring techniques developed by the present inventor. specifically, the haemostasis measuring devices and techniques of the foregoing prior patent applications of the inventor are further modified to study other subsidiary effects contributing to throinbogenesis.
In carrying out the invention, a simulation is made of an artery which is adjacent other human tissue, such that bleeding of the artery communioates with the tissue, which in turn, increases platelet plug-formation. The blood-carrying tube of the hasnostasis measuring device is further provided with A sleeve surrounding the blood-carrying tube, which is punched during a hasmostasis measuring session. Bleeding occurs through the blood-carrying tube into the sleeve member, also punched with a small bleeding hole.As the blood collects between the sleeve and blood-carrying tube, a certain portion of the collected blood comsunicatss with the interior of the blood-carrying tube, generating a throrabus, as is found in blood vessel fissure and rupture.
using the haemostasi# measuring device, it is possible to measure the growth rate and volume of the thrombus by monitoring the pressure of the blood tube downstream from the thrornbus.
As a further development, a technique has been discovered for preparing collagen material for introduction to a tube for measuring the affects of collagen material on platelet formation.
D#scri#tfpn of the Figures Figure 1 illustrates the haemostasis measuring device described of the prior patent application.
Figure 2 is an enlarged view'of the punching needle and a pair of blood supply tubes positioned for simultaneous puncture by needle 10.
Figure 3 illustrates the provision of a sleeve 8 over bloodcarrying tube 2.
Figure 4 illustrates the puncture of the sleeve and bloodcarrying tube 2.
Figure 5 illustrates the formation of a thrombus 26 within the blood tube 2.
Figure 6 illustrates the Puncture of another type of sleeve material 9 which ii an artery from an animal over a tube 2.
Figure 7 illustrates the puncture of material 9 and tube 2 by the punching needle 10.
Figure 8 illustrates the pressure reading by a pressure transduced (PT) downstream of the punching needle during the formation of a thrombus within blood-carrying tube 2 of
Figures 3-5.
Description of tbe Preftrrd ##i:nent Referring now to Figure 1, there is shown one channel from a dual, identical channel instrument for measuring haemostasis.
The instrument includes a columnar container in the form of a 2 ml hypodermic syringe l for holding blood. An elongated polyethylene tube having an internal diameter of 1/2 mm and a length of 30 cm is connected to the syringe 1 by means of a
Luar type connector 3, familiar to those skilled in the art.
The tube 2 is inserted through a pressure-tight rubber seal 4 at the opposite end thereof to a waste blood holding vessel 5. Prior to measuring the properties of a blood sample using the device, the waste holding vessel 5 is filled with paraffin oil 6 and the level of blood 7 in the vessel rises during the investigation.
The syringe 1 is received in the syringe mounting block 8, having an electrical heating element and thermostat associated therewith, to maintain the blood sample at a constant temperature of 37'C. The plunger 9 of the syringe is secured by a lock, not shown, to prevent it, backward movement upon pressurization of blood in the syringe.
The polyethylene tube 2 is threaded through a punching station, generally of the kind described in European Patent Specification No. 1294951 except for the modification of the tube support to provide the punching of more than one polyethylene tube. A punching needle 10 is provided on the punch plunger 11, having sufficient shank length to pierce two parallel disposed blood tubes a. Figure 2 illustrates in detail how the two tubes are positioned with respect to each other to permit the simultaneous punching of both tube;.
Punching needle 10 ii configured to have a diameter of eubstantially .15 mm in order to provide a controlled blooding from the respective polyethylene tubes 2.
The waste blood holding vessel 5 has three parts, a base Sa, a central tubular part 5b, and an upper part Sc. The upper part Sc has an opening 19 to which is affixed a pressure transducer 20. An outlet 21 for paraffin oil is also provided in the upper part So A valve 22 is provided for closing cutlet 21 from the vessel 5.
Parts Sa, Sb and 5c of vessel 5 are assembled as a push fit, and are sealed by O-rings 24 and 25. In operation of the dual channel device, two blood samples are taken from the patient using a respective pair of syringes 1 for the twochannel device. The syringes are placed in the heating block 8 of the apparatus1 and the lower lock connector is connected to the syringe outlet . Respective tubes 2 are then passed through the piercing station, and through rubber seals 4 or two waste holding vessels 5.
Each of the respective syringes 1 is then pierced through its side with a respective hypodermic needle 42 and 43 connected to a paraffin oil supply. Paraffin oil is pumped into the syringes 1 at a rate of approximately .1 ml per minute. The inflowing paraffin oil prevents sedimentation of red Calls in the blood and displaces the blood through the tubing 2. The pressure at the transducer 20 is observed until it is steady with a steady flow of blood entering vessel 5. Tubes of both channels are then simultaneously pierced with a single needle 10 and the pressure at transducer 20 is observed further. A confirmatory check of bleeding through holes 12 is carried out, noting the signal received at a silicon. photodiode smplemented to detect blood droplets.Bleeding from holes 12 causes the amount of light incident to a photodetector to be much reduced, so that the onset and cessation of bleeding can be noted and confirmed.
The foregoing instrument has been used in studies of bleeding and the effects of various coagulants on blood in treating various blood disorders. The foregoing hpparttun is useful in simulating actual in viva conditions, and provide.
clinical studies of the physical properties of blood when treated with various agents.
As an improvement to the foregoing system, it is possible to further increase the in viva simulation by applying a sleeve over the tube, simulating the body tissue normally surrounding the arteries of a patient. The sleeve 2g, shown in Figures 3 and 4, may be of a silicone rubber material, which, when punctured along with the blood-carrying tube 2, will permit blood to escape and be trapped between the sleeve 28 and blood-carrying tube 2. When an acute occlusion arterial thrombus formation occurs in a blood vessel, it generally occurs by either (1) severe narrowing (stenoses) of the vascular lumen; (2) rupture of an atherosclerotic plaque; and, (3) h morrhage related intravascular thrombus.The most f requent mechanism of acute coronary occlusion is a combination of the above factors. It is precipitated by the rupture of plaque and the bleeding into the vessel will result in an occlusive thrombus formation.
The embodiments shown in Figure. 3, 4, 5, 6 and 7 illustrate a laboratory technique for modeling the complex process of thrombus formation. The thrombus model permits astudy of the pathomechanism and the evaluation of drugs which are used to treat thrombogenesis.
The polyethylene tubing 2 in Figures 3, 4 and 5 is surrounded by a silicone rubber sleeve at the punch site. By this arrangement, the needle penetrates both the outer rubber sleeve 28 and the polyethylene tubing. When the needle punches the sleeve 28 and tubing 2 of Figure 4, the blood escapes from the interior of the elongate tube 2 into the space between the sleeve 28 and tube 2, and remains trapped between the tube 2 and sleeve 28. If the source 40 of paraff in oil is pulsed, such that pressure pulses are introduced in the blood flowing in tubes 2, occlusive thrombus 26 forms rapidly in the tube after punching. The thrombus 26 forms as a result of the blood flowing between the tube 2 and sleeve 28.Due to the pulsating nature of the bloodflow in an artery when an atherosclerotic ulcer rupture~, the possibility exists that communication occurs between the main blood flow and extravascular blood. This may, in turn, permit activating factors to reenter the artery lumpen during the pulsating pressure wave occurring in the blood. The sleeve 28 simulates these effects, the sleeve 28 permitting blood exiting the tube puncture to reenter the blooditreain. This effect will result in thrombug formation 26 within the tubing 2 following the arrest of bleeding by haemostatic plugs formed in the punctured hole. The thrombus grows rapidly until approximately 2/3 of the lwaen has been occluded when it is dislodged by the flowing blood.
During this process, the downstream pressure measured by pressure transducer 20 provides the profile shown in Figure 8. Referring further to this Figure, there can be seen the comparison of the channel bearing a sleeve 28 versus a channel having no sleeve 28. When the two channels are simultaneously punched, the measured downstream pressure immedSately drops in both channels. In the channel having the sleeve member 28, shown as the upper trace of figure 8, the pressure will rise until bleeding occurs. This can be seen most clearly from the lower trace of Figure 8 showing the downstream pressure profile of a channel not bearing the sleeve 28.
The region of the upper trace of Figure 8, bounded by the dashed lines, illustrates the formation of a thrombus 26 within the sleeve 28. As the thrombus forms, the downstream pressure decreases as the tube is becoming occluded, reducing the flow rate of blood into the receptacle 6. At a point shown at the lowermost point of the pressure profile1 the pressure begins to rise again, indicating that the thrombus 26 has been dislodged, permitting the free flow of blood to occupy the entire diameter of the tube 2.
Thus, it is seen that the device with the improvements of
Figures 3, 4, 5 and 6 permit an analysis of thro:nbus formation under the influence of any introduced agent. to permit full experimentation to simulate or model occlusive thrombus formation.
As a variant of the foregoing technique, arterial vessel material 9 from an animal may be used in place of the silicone rubber seal. The use of animal blood vessel simulating the in vivo situation permits a full range of experimentation and conditions to be produced for examining occlusive thrombus formation.
In deriving the foregoing techniques for measuring thrombus formation, a method has been discovered for preparing surgical catgut suture for us. in measuring platelet formation in accordance with the aforesaid patent.
Commercially surgical catgut suture is normally provided in 75-150 cm lengths, rolled up and sealed in an alcohol solution. In preparing this collagen material for insertion in a blood-carrying tube of the haemostasis measuring device, catgut is permitted to dry at room temperature. The catgut is tensioned with a small weight, approximately 25 grams, and then moistened by a cotton wool pallet, soaked with distilled water. The wet catgut1 suspended by the weight, is let dry at room temperature. The brsimple procedure results in a straight line of catgut having uniform and standard diameter.
The catgut is then cut by a scalpel into segments 8and stored in a sealed tube. Immediately before testing in the haemostasis measuring device, one of these cut segments of catgut is placed in a Finn's forcep into the lumen of the polyethylene tubing, in which blood will be perfused. To prevent movement of the catgut in the blood tube during blood flow, a loop is formed from the polyethylene tubing housing the collagen fiber, downstream of the collagen fiber; the sharp curvature of the tubing does not impede the pertusion flow, but prevent. the fiber from traveling along in the tubing when the resistance due to thrombus formation on collagen ii increased.
Following this simple preparation technique permits accurate, reliable and repeatable data to be obtained to measure platelet thrombus-formation from different blood samples.
There has thus been demonstrated some improvements on the basic heemostasis technology for permitting the modeling of occlusive thrombus formation in the lumen of a blood vessel.
Those skilled in the art will recognize yet other embodiments described more particularly by the claims which follow.
Claims (10)
1. A method for modeling occlusive thrombosis formations
comprising;
supplying blood from a pressur & ed blood reservoir to a
tubing which passes through a punching station to a
collection reservoir; providing a sleeve over said tubing in a portion of the
tube which pa#ses through said punching station;
punching a needle hole in said sleeve and tube to
simulate bleeding, whereby blood exits said tubing, z portion of said blood being trapped between said tubing
and sleeve, some of the trapped blood mixing with blood
through said tube, forming a thrombus which increases in
size with time, and subsequently roves past said
punching station: and, meaSuring the pressure in said tube to identify the
formation of the ffirombus.
2. The method of claim 1 wherein said sleeve is a silicone
rubber sleeve.
3. The method of claim 1 further comprising a length of
animal blood vessel surrounding said tube, which is
punched with said tube, whereby the effect of said blood
vessel material on the thrombus formation may be
determined.
4. The method of claim 1 further comprising establishing a pulsamatile flow in said tube by pulsatile pumping a
displacing medium into said reservoir.
5. Ar. apparatus for modeling occlusion thrombosis in vitro
comprising:
a reservoir of blood including an outlet, and source of
pressuring media for forcing blood through said outlet;
an elongate tube connected to one end to said outlet,
having a portion which passes through a punching station
and connected at another end to a waste receptacle;
a sleeve member disposed over said elongate tube
portion, positioned to be pierced by a needle of said
punching ~station, whereby blood exits said tubing and is
trapped between said elongate tube exterior wall and
said sleeve interior wall, said trapped blood inducing a
thrombus in said elongate tuber and,
a pressure gauge connected to monitor the fluid pressure
in said elongate tube doxmstream from said punching
station.
6. The apparatus for modeling occlusion thrombosis in vitro
of claim 5 comprising means for pulsing said source of
pressurizing media to pulse blood flowing in said
elongate tube.
7. The apparatus of claim 5 wherein said sleeve is made
from silicone rubber.
8. The apparatus of claim 5 further comprising a section of
animal blood vessel disposed over said tube.
9. A method for permitting analysis of the effect of
collagen material on platelet formation comprising:
inserting B length of collagen material in a flexible tube; forming a loop in said flexible tube;
connecting said flexible tube member between a reservoir
of blood and a discharge receptacle so that said loop is downstream of said collagen material; and,
establishing a flow of blood in ~aid tube whereby platelet formation about said collagen may be observed.
10. The method of claim 9 further comprising preparing said
collagen material for insertion in said tube comprising
the steps of:
tensioning a length of surgical catgut;
moistening said length of catgut whereby a length of
catgut having a uniform diameter results; and,
cutting said length of catgut into standard lengths for
use in later conducted analyses of platelet formation
Priority Applications (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9006520A GB2245061A (en) | 1990-03-23 | 1990-03-23 | Modelling thrombosis formation |
| PCT/GB1991/000438 WO1991014943A1 (en) | 1990-03-23 | 1991-03-22 | Apparatus and method for modeling arterial thrombus formations |
| US07/927,284 US5296379A (en) | 1990-03-23 | 1991-03-22 | Apparatus and method for modeling arterial thrombus formations |
| AU75427/91A AU7542791A (en) | 1990-03-23 | 1991-03-22 | Apparatus and method for modeling arterial thrombus formations |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9006520A GB2245061A (en) | 1990-03-23 | 1990-03-23 | Modelling thrombosis formation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| GB9006520D0 GB9006520D0 (en) | 1990-05-23 |
| GB2245061A true GB2245061A (en) | 1991-12-18 |
Family
ID=10673112
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB9006520A Withdrawn GB2245061A (en) | 1990-03-23 | 1990-03-23 | Modelling thrombosis formation |
Country Status (3)
| Country | Link |
|---|---|
| AU (1) | AU7542791A (en) |
| GB (1) | GB2245061A (en) |
| WO (1) | WO1991014943A1 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002041285A3 (en) * | 2000-11-17 | 2003-07-31 | David Levy | Medical simulation apparatus and related method |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0129425A2 (en) * | 1983-06-15 | 1984-12-27 | Peter Gorog | Method and apparatus for measuring haemostasis and thrombolysis |
| WO1988002116A1 (en) * | 1986-09-10 | 1988-03-24 | Peter Gorog | Blood testing device |
-
1990
- 1990-03-23 GB GB9006520A patent/GB2245061A/en not_active Withdrawn
-
1991
- 1991-03-22 AU AU75427/91A patent/AU7542791A/en not_active Abandoned
- 1991-03-22 WO PCT/GB1991/000438 patent/WO1991014943A1/en not_active Ceased
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0129425A2 (en) * | 1983-06-15 | 1984-12-27 | Peter Gorog | Method and apparatus for measuring haemostasis and thrombolysis |
| WO1988002116A1 (en) * | 1986-09-10 | 1988-03-24 | Peter Gorog | Blood testing device |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002041285A3 (en) * | 2000-11-17 | 2003-07-31 | David Levy | Medical simulation apparatus and related method |
Also Published As
| Publication number | Publication date |
|---|---|
| GB9006520D0 (en) | 1990-05-23 |
| AU7542791A (en) | 1991-10-21 |
| WO1991014943A1 (en) | 1991-10-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5296379A (en) | Apparatus and method for modeling arterial thrombus formations | |
| CA1341179C (en) | Blood testing device | |
| Matsen et al. | Monitoring of intramuscular pressure | |
| US5854423A (en) | Apparatus and method for assessment of visco-elasticity and shear adherence strength properties of blood clots | |
| US5316730A (en) | Disposable cartridge for investigating physical properties of blood | |
| JPH10506471A (en) | In-situ calibration system for sensors in physiological lines | |
| Smaje et al. | The distensibility of single capillaries and venules in the cat mesentery | |
| JPH05502936A (en) | Disposable blood manipulation cassette device for blood congestion measurement | |
| NO170128B (en) | PROCEDURE FOR THE CREATION OF A MONOCLONAL ANTIBODY FOR USE AS A DIAGNOSTIC POSITION-SPECIFIC REAGENT | |
| CN109900885A (en) | Interventional medical equipment and medical material test macro and corresponding experimental method | |
| US5916813A (en) | Thrombotic and/or thrombolytic status analyser | |
| US5432084A (en) | Device for in vitro bleeding time determination | |
| Smith et al. | Clinical application of transcutaneous oxygen measurements in replantation surgery and free tissue transfer | |
| EP0575576A1 (en) | Measurement of the thrombolytic activity of blood. | |
| Harrison et al. | Methods of assessing the viability of free flap transfer during the postoperative period | |
| US6004819A (en) | Blood testing device | |
| GB2245061A (en) | Modelling thrombosis formation | |
| EP0495801A1 (en) | Probe for blood gas sensing | |
| EP0129425B1 (en) | Method and apparatus for measuring haemostasis and thrombolysis | |
| Shangguan et al. | Microsecond laser ablation of thrombus and gelatin under clear liquids: Contact versus noncontact | |
| JP4793651B2 (en) | Sheath removal hole closing device using laser welding | |
| Jussila et al. | Tissue gas tensions in the calf muscles of patients with lower limb arterial ischaemia | |
| EP0111551A1 (en) | METHOD AND DEVICE FOR DIRECT AND IMMEDIATE MEASUREMENT OF BLOOD VISCOSITY. | |
| CA2205229A1 (en) | Blood vessel graft quality evaluation | |
| JP2003344391A (en) | Implement and method for measuring rate of blood platelet stagnation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| WAP | Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1) |